Oral contraceptives and low antithrombin-3 activity

Rapid increase of fibrinolytic activity in pig and rat after exclusion of the liver from the circulation and its control by various organs.

Acta hepato-gastroenterologica·1979

The powerful urinary procoagulant and its relation to renal diseases.

Current problems in clinical biochemistry·1979

[On the normalization of the content of human urine of procoagulant after renal transplantation (author's transl)].

Klinische Wochenschrift·1978

Structure-activity relationship in synthetic fibrinolytics. 2-Phenethynylcyclopropanecarboxylates.

Journal of medicinal chemistry·1975

Conjugated estrogens and hypercoagulability.

American journal of obstetrics and gynecology·1975

In vitro inhibition of aggregation of human erythrocytes by synthetic fibrinolytic compounds.

Arzneimittel-Forschung·1975

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Fertility Treatment Using Assisted Reproductive Technology During Immune Checkpoint Inhibition: Report of Two Cases.

The oncologist·2026

Reproductive healthcare use before and after infertility diagnosis: a population-based study in South Korea.

BMJ open·2026

Cost-effectiveness of safer conception strategies for HIV-discordant couples in Zimbabwe.

Journal of acquired immune deficiency syndromes (1999)·2026

Late-follicular androgen and estrogen rise associated with clinical pregnancy in IVF/ICSI with granulosa cell studies.

Reproduction & fertility·2026

Innovative treatment approaches for azoospermia: causes, emerging techniques, and future directions.

Molecular biology reports·2026

Effect of patient and partner preconceptional nutraceutical supplementation on the onset of natural pregnancy: a retrospective study.

Revista da Associacao Medica Brasileira (1992)·2026

Related Experiment Videos

Oral contraceptives and low antithrombin-3 activity

Related Concept Videos

Rapid increase of fibrinolytic activity in pig and rat after exclusion of the liver from the circulation and its control by various organs.

The powerful urinary procoagulant and its relation to renal diseases.

[On the normalization of the content of human urine of procoagulant after renal transplantation (author's transl)].

Structure-activity relationship in synthetic fibrinolytics. 2-Phenethynylcyclopropanecarboxylates.

Conjugated estrogens and hypercoagulability.

In vitro inhibition of aggregation of human erythrocytes by synthetic fibrinolytic compounds.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Fertility Treatment Using Assisted Reproductive Technology During Immune Checkpoint Inhibition: Report of Two Cases.

Reproductive healthcare use before and after infertility diagnosis: a population-based study in South Korea.

Cost-effectiveness of safer conception strategies for HIV-discordant couples in Zimbabwe.

Late-follicular androgen and estrogen rise associated with clinical pregnancy in IVF/ICSI with granulosa cell studies.

Innovative treatment approaches for azoospermia: causes, emerging techniques, and future directions.

Effect of patient and partner preconceptional nutraceutical supplementation on the onset of natural pregnancy: a retrospective study.

Related Experiment Videos

Oral contraceptives and low antithrombin-3 activity

Related Concept Videos

Related Articles